Type 2 diabetes therapeutic strategies: why don't we see the «ELEPHANT» in the room?

por Shmuel Levit, Shmuel Giveon, Yury I. Philippov, Ivan Panchev Domuschiev, Amir Zivony
Publicado 2016

Development and in silico validation of the PID-algorithm for the artificial pancreas with intraperitoneal insulin delivery

por Vladimir A. Karpelyev, Yury I. Philippov, Artem V. Averin, Maxim D. Boyarsky, Dmitriy A. Gavrilov
Publicado 2018

Comparative analysis of glycemic control effectiveness and microvascular complications in patients with type 1 diabetes mellitus, treated with genetically engineered human insulin...

por Marina V. Shestakova, Natalia V. Efremova, Lubov L. Bolotskaya, Igor A. Sklyanik, Yury I. Philippov, Ivan Iю Dedov
Publicado 2016

Free-living use of artificial pancreas for children with type 1 diabetes: systematic review

por Klemen Dovc, Gül Yeşiltepe Mutlu, Yury I. Philippov, Dmitry N. Laptev, Evgenia M. Patrakeeva, Lubov O. Chernilova, Alsu G. Zalevskaya, Marina V. Shestakova, Tadej Battelino
Publicado 2018